Sage Journals: Discover world-class research

Retricted access

Research article

First published 2014-01

Overcoming T790M-driven Acquired Resistance to EGFR-TKIs in NSCLC with Afatinib: A Case Report

Paola Bordi, Marcello Tiseo, Beatrice Bortesi [...]

Tumori Journal

Open access

Review article

First published 2022

Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer

Jiyun Lee, Zofia Piotrowska, Ross Soo [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2015-5

Transformation to Small Cell Lung Cancer as an Acquired Resistance Mechanism in EGFR -mutant Lung Adenocarcinoma: A Case Report of Complete Response to Etoposide and Cisplatin

Ki-Eun Hwang, Jae-Wan Jung, Su-Jin Oh [...]

Tumori Journal

Open access

Review article

First published 2018

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Vera Hirsh

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2021-12

Transformation of advanced lung adenocarcinoma to acquired T790M resistance mutation adenosquamous carcinoma following tyrosine kinase inhibitor: a case report

Qinghan Liu, Lin Wu, Suning Zhang

Tumori Journal

Retricted access

Letter

First published 2022-4

Combination EGFR and RET Inhibition in Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC

Jessica Freydman, Lynnette Henshaw, Jasmine V. Patel [...]

Annals of Pharmacotherapy

Free access

Research article

First published 2020-8

MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process

Hsin-Yi Wang, Yi-Nan Liu, Shang-Gin Wu [...]

Cancer Biomarkers

Open access

Review article

First published 2019

Second-line treatment of EGFR T790M-negative non-small cell lung cancer patients

Bin-Chi Liao, Sebastian Griesing, James Chih-Hsin Yang

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2018-4

Concomitant Presence of EGFR and ALK Fusion Gene Mutation in Adenocarcinoma of Lung: A Case Report and Review of the Literature

Nishitha Thumallapally, Hana Yu, Mohammad Farhan [...]

Journal of Pharmacy Practice

Free access

Review article

First published 2016-5

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

Ourania Romanidou, Lorenza Landi, Federico Cappuzzo [...]

Therapeutic Advances in Medical Oncology

Search results